Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula

Abstract

The invention relates to a clinical nutrient formula special for tumor and a preparation method of the clinical nutrient formula. The clinical nutrient formula is prepared from the following raw materials: proteins, fat, a carbohydrate, dietary fibers, macroelements, trace elements, fat-soluble vitamins, water-soluble vitamins, a medicinal and edible component, a natural plant compound and new resource food, wherein the medicinal and edible component is selected from at least one of hawthorns, sea-buckthorn, poria cocos, sealwort, chrysanthemum, dandelion, lilies and fermented soybean; all the components are prepared into powder; the fat is prepared into powdered oil by adopting a micro capsule embedding technology. Due to screening and proportioning of the components, the nutrient formula disclosed by the invention can supply comprehensive nutrition support to a tumor patient and substantially increase the biological value of the proteins; moreover, due to the adding of the components capable of enhancing the immunity and resisting the tumor, the physique of the tumor patient can be enhanced, and malnutrition which possibly occurs or exists can be prevented or corrected; the nutrition supporting effect is enhanced, so that the patient can bear a complete chemotherapy process.

Description

technical field

[0001] The invention relates to the field of formula food for special medical purposes, in particular to a tumor-specific clinical nutritional formula and a preparation method thereof. Background technique

[0002] Cancer is the top 10 leading cause of death in the world, and the incidence rate is increasing year by year. According to the statistics of WHO, there were about 14 million new cancer cases and 8.2 million cancer-related deaths in the world in 2012; the number of new cases is expected to increase by about 70% in the next two decades. With the trend of economic growth and population aging in my country, the growth rate of cancer cases will be more significant.

[0003] At present, clinically, tumor treatment mainly adopts a combination of surgery and chemotherapy or radiotherapy. However, the incidence of malnutrition in cancer patients is quite high. Many cancer patients undergo repeated radiotherapy and chemotherapy under the condition of malnut...

Examples

Embodiment 1

[0055] The tumor-specific clinical nutritional formula of the present invention includes 9.8g of whey protein powder, 5.18g of soybean protein isolate, 26.31g of whole milk powder, 0.18g of whole egg powder, 0.1g of bovine colostrum, 0.11g of taurine, soybean Oligopeptide 0.1g, marine fish oligopeptide powder 0.1g; olive oil 16.6g, soybean oil 4.9g, coconut oil 0.49g, perilla oil 3.49g, medium chain triglyceride 0.49g; maltodextrin 8.25g, Tapioca starch 1.82g, resistant starch 1.82g; dietary fiber selected from inulin, konjac flour, galacto-oligosaccharides, fructo-oligosaccharides, isomalto-oligosaccharides, soybean polysaccharides, cyclodextrin, resistant dextrin, soybean fiber At least one of them, the total mass of which is 7.82g, including 6g of water-soluble dietary fiber and 1.82g of insoluble dietary fiber; 0.4g of calcium, 0.25g of phosphorus, 0.08g of potassium, 0.02g of sodium, and 0.15g of magnesium in macroelements; Iron 0.011g, iodine 0.00014g, zinc 0.007g; fat-s...

Embodiment 2

[0057] The tumor-specific clinical nutritional formula of the present invention includes 7.8g of whey protein powder, 7.18g of soybean protein isolate, 26.31g of whole milk powder, 0.18g of whole egg powder, 0.1g of bovine colostrum, 0.11g of taurine, soybean Oligopeptide 0.1g, marine fish oligopeptide powder 0.1g; olive oil 19.6g, soybean oil 4.9g, coconut oil 0.49g, perilla oil 0.49g, medium chain triglyceride 0.49g; maltodextrin 8.25g, Tapioca starch 1.82g, resistant starch 1.82g; dietary fiber selected from inulin, konjac flour, galacto-oligosaccharides, fructo-oligosaccharides, isomalto-oligosaccharides, soybean polysaccharides, cyclodextrin, resistant dextrin, soybean fiber At least one of them, the total mass of which is 7.82g, including 6g of water-soluble dietary fiber and 1.82g of insoluble dietary fiber; 0.4g of calcium, 0.25g of phosphorus, 0.08g of potassium, 0.02g of sodium, and 0.15g of magnesium in macroelements; Iron 0.011g, iodine 0.00014g, zinc 0.007g; fat-s...

Embodiment 3

[0059]The tumor-specific clinical nutritional formula of the present invention includes 7.8g of whey protein powder, 7.18g of soybean protein isolate, 26.31g of whole milk powder, 0.18g of whole egg powder, 0.1g of bovine colostrum, 0.11g of taurine, soybean Oligopeptide 0.1g, marine fish oligopeptide powder 0.1g; olive oil 19.6g, soybean oil 4.9g, coconut oil 0.49g, perilla oil 0.49g, medium chain triglyceride 0.49g; maltodextrin 11.25g, Tapioca starch 1.82g, resistant starch 1.82g; dietary fiber selected from inulin, konjac flour, galacto-oligosaccharides, fructo-oligosaccharides, isomalto-oligosaccharides, soybean polysaccharides, cyclodextrin, resistant dextrin, soybean fiber At least one of them, the total mass of which is 7.82g, including 6g of water-soluble dietary fiber and 1.82g of insoluble dietary fiber; 0.4g of calcium, 0.25g of phosphorus, 0.08g of potassium, 0.02g of sodium, and 0.15g of magnesium in macroelements; Iron 0.011g, iodine 0.00014g, zinc 0.007g; fat-s...

technical field

[0001] The invention relates to the field of formula food for special medical purposes, in particular to a tumor-specific clinical nutritional formula and a preparation method thereof. Background technique

[0002] Cancer is the top 10 leading cause of death in the world, and the incidence rate is increasing year by year. According to the statistics of WHO, there were about 14 million new cancer cases and 8.2 million cancer-related deaths in the world in 2012; the number of new cases is expected to increase by about 70% in the next two decades. With the trend of economic growth and population aging in my country, the growth rate of cancer cases will be more significant.

[0003] At present, clinically, tumor treatment mainly adopts a combination of surgery and chemotherapy or radiotherapy. However, the incidence of malnutrition in cancer patients is quite high. Many cancer patients undergo repeated radiotherapy and chemotherapy under the condition of malnut...

Examples

Embodiment 1

[0055] The tumor-specific clinical nutritional formula of the present invention includes 9.8g of whey protein powder, 5.18g of soybean protein isolate, 26.31g of whole milk powder, 0.18g of whole egg powder, 0.1g of bovine colostrum, 0.11g of taurine, soybean Oligopeptide 0.1g, marine fish oligopeptide powder 0.1g; olive oil 16.6g, soybean oil 4.9g, coconut oil 0.49g, perilla oil 3.49g, medium chain triglyceride 0.49g; maltodextrin 8.25g, Tapioca starch 1.82g, resistant starch 1.82g; dietary fiber selected from inulin, konjac flour, galacto-oligosaccharides, fructo-oligosaccharides, isomalto-oligosaccharides, soybean polysaccharides, cyclodextrin, resistant dextrin, soybean fiber At least one of them, the total mass of which is 7.82g, including 6g of water-soluble dietary fiber and 1.82g of insoluble dietary fiber; 0.4g of calcium, 0.25g of phosphorus, 0.08g of potassium, 0.02g of sodium, and 0.15g of magnesium in macroelements; Iron 0.011g, iodine 0.00014g, zinc 0.007g; fat-s...

Embodiment 2

[0057] The tumor-specific clinical nutritional formula of the present invention includes 7.8g of whey protein powder, 7.18g of soybean protein isolate, 26.31g of whole milk powder, 0.18g of whole egg powder, 0.1g of bovine colostrum, 0.11g of taurine, soybean Oligopeptide 0.1g, marine fish oligopeptide powder 0.1g; olive oil 19.6g, soybean oil 4.9g, coconut oil 0.49g, perilla oil 0.49g, medium chain triglyceride 0.49g; maltodextrin 8.25g, Tapioca starch 1.82g, resistant starch 1.82g; dietary fiber selected from inulin, konjac flour, galacto-oligosaccharides, fructo-oligosaccharides, isomalto-oligosaccharides, soybean polysaccharides, cyclodextrin, resistant dextrin, soybean fiber At least one of them, the total mass of which is 7.82g, including 6g of water-soluble dietary fiber and 1.82g of insoluble dietary fiber; 0.4g of calcium, 0.25g of phosphorus, 0.08g of potassium, 0.02g of sodium, and 0.15g of magnesium in macroelements; Iron 0.011g, iodine 0.00014g, zinc 0.007g; fat-s...

Embodiment 3

[0059]The tumor-specific clinical nutritional formula of the present invention includes 7.8g of whey protein powder, 7.18g of soybean protein isolate, 26.31g of whole milk powder, 0.18g of whole egg powder, 0.1g of bovine colostrum, 0.11g of taurine, soybean Oligopeptide 0.1g, marine fish oligopeptide powder 0.1g; olive oil 19.6g, soybean oil 4.9g, coconut oil 0.49g, perilla oil 0.49g, medium chain triglyceride 0.49g; maltodextrin 11.25g, Tapioca starch 1.82g, resistant starch 1.82g; dietary fiber selected from inulin, konjac flour, galacto-oligosaccharides, fructo-oligosaccharides, isomalto-oligosaccharides, soybean polysaccharides, cyclodextrin, resistant dextrin, soybean fiber At least one of them, the total mass of which is 7.82g, including 6g of water-soluble dietary fiber and 1.82g of insoluble dietary fiber; 0.4g of calcium, 0.25g of phosphorus, 0.08g of potassium, 0.02g of sodium, and 0.15g of magnesium in macroelements; Iron 0.011g, iodine 0.00014g, zinc 0.007g; fat-s...

Images